Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Measurement of Bioavailability: Pharmacokinetic Methods

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...

Measurement of Bioavailability: Pharmacodynamic Methods

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Polycyclic aromatic compounds in gull and tern eggs from breeding sites downstream of Athabasca oil sands mines (Alberta, Canada).

Environmental research·2026

Same author

Challenges in applying high energy water accommodated fractions in oil toxicity testing.

Chemosphere·2026

Same author

Using chemometrics to discern patterns and spatial distribution of heterocyclic aromatic compounds in Lake Erie fish.

Environmental pollution (Barking, Essex : 1987)·2026

Same author

Heterocyclic Aromatic Compounds: The Next Frontier in Environmental Forensic Science.

Environmental science & technology·2026

Same author

Habitat and diet affect bioaccumulation of homocyclic and heterocyclic aromatic compounds in Lake Erie fish.

Journal of hazardous materials·2026

Same author

Species- and Tissue-Specific Accumulation of Polycyclic Aromatic Compounds in Three Arctic Seabirds.

Environmental science & technology·2026

Search research articles

Related Experiment Video

Updated: May 30, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Comparing laboratory and field measured bioaccumulation endpoints.

Lawrence P Burkhard¹, Jon A Arnot, Michelle R Embry

¹US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, 6201 Congdon Boulevard, Duluth, Minnesota 55804, USA. burkhard.lawrence@epa.gov

Integrated Environmental Assessment and Management

|July 28, 2011

Summary

A new method standardizes bioaccumulation data using fugacity ratios, enabling consistent comparison of laboratory and field measurements for biomagnification and biodilution potential. This approach aids chemicals management decisions.

More Related Videos

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey

Published on: August 29, 2014

A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms

A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms

Published on: January 11, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey

Published on: August 29, 2014

A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms

A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms

Published on: January 11, 2015

Area of Science:

Environmental Chemistry
Ecotoxicology
Chemical Risk Assessment

Background:

Bioaccumulation data from laboratory and field studies often use different scales and units, hindering direct comparison.
Interpreting diverse bioaccumulation metrics (e.g., BCF, BAF, BSAF, BMF, TMF) requires a unified framework.

Purpose of the Study:

To present a novel approach for comparing diverse bioaccumulation metrics by converting them to dimensionless fugacity ratios.
To facilitate a holistic, weight-of-evidence assessment of a chemical's biomagnification or biodilution potential.

Main Methods:

Data from 171 reports (2393 data points) for 15 nonionic organic chemicals were analyzed.
Bioaccumulation metrics were converted to dimensionless fugacity ratios, normalizing for differences in scales and units.
Fugacity ratios were plotted to visualize variability and compare laboratory and field data.

Main Results:

Fugacity ratios effectively standardized diverse bioaccumulation metrics, allowing for direct comparison.
Laboratory and field-derived fugacity ratios generally agreed in categorizing chemicals as biomagnifying (ratio > 1) or biodiluting (ratio < 1).
The approach demonstrated consistency across various bioaccumulation endpoints.

Conclusions:

The proposed comparative bioaccumulation endpoint assessment method provides a reliable tool for evaluating biomagnification potential.
This standardized approach enhances the interpretation of bioaccumulation data for chemicals management and risk assessment.
The method supports a weight-of-evidence approach by integrating multiple bioaccumulation metrics.